Comparison of Sonographic and MRI Weight Estimation in Fetuses with Suspected Macrosomia
Launched by WESTERN GALILEE HOSPITAL-NAHARIYA · Mar 25, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the accuracy of two different methods for estimating the weight of a baby in the womb when there are concerns that the baby may be larger than normal, a condition known as macrosomia. The two methods being compared are sonography (an ultrasound technique) and magnetic resonance imaging (MRI). Pregnant women who are nearing the end of their pregnancy and have been identified as having a potentially large baby may be eligible to participate.
Participants will receive both a sonogram and an MRI to estimate their baby’s weight, and then the actual weight of the baby at birth will be measured. This information will help researchers understand which method provides a more accurate estimate. Eligible participants must be having a single pregnancy that is close to term and have a suspicion of macrosomia. Those with certain conditions, like multiple pregnancies or specific fetal abnormalities, cannot take part in the study. It's important for participants to know that their involvement can help improve how doctors estimate fetal weight in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • singleton pregnancy at term, suspected fetal macrosomia,
- Exclusion Criteria:
- • fetal anomaly multiple pregnancy PROM
About Western Galilee Hospital Nahariya
Western Galilee Hospital-Nahariya is a leading medical institution located in Israel, dedicated to providing high-quality healthcare services and advancing medical research. As a prominent clinical trial sponsor, the hospital focuses on innovative therapeutic developments across various medical fields, aiming to enhance patient outcomes through rigorous scientific inquiry. With a commitment to ethical standards and patient safety, Western Galilee Hospital-Nahariya collaborates with multidisciplinary teams of healthcare professionals and researchers to facilitate cutting-edge clinical trials that contribute to the advancement of medical knowledge and the improvement of treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nahariyya, , Israel
Patients applied
Trial Officials
Amal shahin
Principal Investigator
Galilee Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported